三孚股份(603938.SH):董事長孫任靖擬減持不超6%的股份
格隆匯5月12日丨三孚股份(603938.SH)公佈,公司控股股東、董事長孫任靖擬通過大宗交易、集中競價等上海證券交易所認可的合法方式減持IPO前取得並經2020年度權益分派送股的公司股票,減持比例不超過其所持有公司股份的15%,共計不超過1171.2萬股,減持比例不超過6%。
萬柏峯、董立強、陳治宏、周連會、王化利、張文博、魏躍剛擬通過集中競價方式減持其IPO前取得並經2020年度權益分派送股的公司股票,減持比例不超過其所持有公司股份的25%,即萬柏峯擬減持將不超過23.2萬股;董立強、陳治宏、周連會擬減持將不超過3.1萬股;王化利擬減持將不超過9100股;張文博、魏躍剛擬減持將不超過5400股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.